Clinical heterogeneity of drug hypersensitivity
Top Cited Papers
- 15 April 2005
- journal article
- review article
- Published by Elsevier BV in Toxicology
- Vol. 209 (2), 123-129
- https://doi.org/10.1016/j.tox.2004.12.022
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Delayed Drug Hypersensitivity ReactionsAnnals of Internal Medicine, 2003
- IFN-γ–producing effector CD8+ T cells and IL-10–producing regulatory CD4+ T cells in fixed drug eruptionJournal of Allergy and Clinical Immunology, 2003
- T-cell involvement in drug-induced acute generalized exanthematous pustulosisJCI Insight, 2001
- Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptionsJournal of Allergy and Clinical Immunology, 2000
- Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndromeBritish Journal of Dermatology, 1998
- Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashesArchives of Dermatology, 1997
- Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): Structure and results of a population-based registryJournal of Clinical Epidemiology, 1996
- Severe Adverse Cutaneous Reactions to DrugsThe New England Journal of Medicine, 1994
- Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiformeArchives of Dermatology, 1993
- Acute generalized exanthematous pustulosis. Analysis of 63 casesArchives of Dermatology, 1991